title: The effect of cisapride on oesophageal motility and lower sphincter function in patients with gastro-oesophageal reflux disease.
abstract: OBJECTIVE
  To evaluate the efficiency by which the 5-HT4 agonist cisapride affects important motor functions involved in the control of gastro-oesophageal reflux.
  
  
  METHODS
  Thirty patients with proven gastro-oesophageal reflux disease (endoscopy and 24 h pH-metry) were included in a randomized, double-blind, placebo controlled study with a cross-over design. Cisapride, 20 mg b.i.d., during 4 weeks was compared with placebo. At baseline, as well as after 4 and 8 weeks all patients underwent symptom assessments, sleeve manometry with concomitant oesophageal pH-monitoring and an acid clearance test.
  
  
  RESULTS
  Despite adequate plasma levels cisapride had no significant effect on swallow induced peristaltic amplitude, duration, propagation speed, the elicitation of secondary peristalsis nor on acid clearance. Neither the basal tone of the lower oesophageal sphincter nor the number of transient lower oesophageal sphincter relaxations induced by gas distension of the stomach was affected by the administered dose of cisapride.
  
  
  CONCLUSIONS
  Although cisapride has been alleged to improve symptoms as well as the oesophagitis in patients with gastro-oesophageal reflux disease, we found the compound (20 mg b.i.d.) devoid of effects on important motor mechanisms involved in the pathogenesis of the disease.
authors.affiliation: Departments of Otorhinolaryngology and Surgery, Sahlgrenska University Hospital, 413 45 Göteborg, Sweden.
authors.forename: Caterina
authors.initials: C
authors.lastname: Finizia
authors.forename: Lars
authors.initials: L
authors.lastname: Lundell
authors.forename: Lars
authors.initials: L
authors.lastname: Cange
authors.forename: Magnus
authors.initials: M
authors.lastname: Ruth
mesh_terms: D000328:Adult; D000368:Aged; D020117:Cisapride / Q000494:pharmacology / Q000627:therapeutic use*; D018592:Cross-Over Studies; D004311:Double-Blind Method; D004943:Esophagogastric Junction / Q000187:drug effects*; D005260:Female; D005764:Gastroesophageal Reflux / Q000188:drug therapy*; D005765:Gastrointestinal Agents / Q000494:pharmacology / Q000627:therapeutic use*; D006801:Humans; D008297:Male; D008365:Manometry; D008875:Middle Aged; D017366:Serotonin Receptor Agonists / Q000494:pharmacology / Q000627:therapeutic use*
chemical_list: D005765:Gastrointestinal Agents; D017366:Serotonin Receptor Agonists; D020117:Cisapride